Find all
associated with


Refine your query (more in Advanced-Search):
 Focus on the recent 5 years   Focus on the current year   Focus on the last 30 days   More choices ...
 Focus on articles with free fulltexts   More choices ...
 Do simple 'keyword' search (no query expansion)

[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 10 of about 1259689
1. Albert M, Corsilli D, Williamson DR, Brosseau M, Bellemare P, Delisle S, Nguyen AQ, Varin F: Comparison of inhaled milrinone, nitric oxide and prostacyclin in acute respiratory distress syndrome. World J Crit Care Med; 2017 Feb 04;6(1):74-78

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparison of inhaled milrinone, nitric oxide and prostacyclin in acute respiratory distress syndrome.
  • METHODS: Open-label prospective cross-over pilot study where fifteen adult patients with hypoxemic failure meeting standard ARDS criteria and monitored with a pulmonary artery catheter were recruited in an academic 24-bed medico-surgical intensive care unit.
  • Thereafter, inhaled milrinone (1 mg/mL) alone followed by inhaled milrinone in association with inhaled nitric oxide (iNO) was administered.
  • RESULTS: The majority of ARDS were of pulmonary cause (<i>n</i> = 13) and pneumonia (<i>n</i> = 7) was the leading underlying initial disease.
  • Other pulmonary causes of ARDS were: Post cardiopulmonary bypass (<i>n</i> = 2), smoke inhalation injury (<i>n</i> = 1), thoracic trauma and pulmonary contusions (<i>n</i> = 2) and aspiration (<i>n</i> = 1).
  • Two patients had an extra pulmonary cause of ARDS: A polytrauma patient and an intra-abdominal abscess Inhaled nitric oxide, epoprostenol, inhaled milrinone and the combination of inhaled milrinone and iNO had no impact on systemic hemodynamics.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Respir Crit Care Med. 1996 Mar;153(3):991-6 [8630585.001]
  • [Cites] J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Mar 1;877(7):657-60 [19201666.001]
  • [Cites] J Intensive Care Med. 2006 May-Jun;21(3):119-43 [16672636.001]
  • [Cites] Intensive Care Med. 2009 Jan;35(1):171-8 [18972099.001]
  • [Cites] N Engl J Med. 1993 Feb 11;328(6):399-405 [8357359.001]
  • [Cites] Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1671-7 [8970353.001]
  • [Cites] Can J Anaesth. 2005 Dec;52(10):1076-82 [16326679.001]
  • [Cites] Anesthesiology. 1995 Jun;82(6):1507-11 [7793662.001]
  • [Cites] Anesth Analg. 2011 Jun;112(6):1411-21 [21372277.001]
  • [Cites] N Engl J Med. 2005 Dec 22;353(25):2683-95 [16371634.001]
  • [Cites] Anesthesiology. 2002 Jun;96(6):1504-13 [12170067.001]
  • [Cites] Anesth Analg. 2001 Dec;93(6):1439-45, table of contents [11726420.001]
  • (PMID = 28224110.001).
  • [ISSN] 2220-3141
  • [Journal-full-title] World journal of critical care medicine
  • [ISO-abbreviation] World J Crit Care Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Acute respiratory distress syndrome / Hypoxemia / Inhaled milrinone / Nitric oxide / Prostacyclin / Pulmonary hypertension
  •  go-up   go-down


2. Junot S, Keroak S, Del Castillo JRE, Ayoub JY, Paquet C, Bonnet-Garin JM, Troncy E: Inhaled nitric oxide prevents NSAID-induced renal impairment in pseudo-normovolaemic piglets. PLoS One; 2017;12(6):e0179475
Hazardous Substances Data Bank. NITRIC OXIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inhaled nitric oxide prevents NSAID-induced renal impairment in pseudo-normovolaemic piglets.
  • OBJECTIVE: Inhaled nitric oxide (iNO) is commonly used as a treatment of pulmonary hypertension.
  • The objective of this study was to evaluate if iNO could compensate the renal impairment induced by ketoprofen, a conventional non-steroidal anti-inflammatory drug (NSAID), during general anaesthesia.
  • [MeSH-major] Anti-Inflammatory Agents, Non-Steroidal. Ketoprofen. Kidney Diseases / prevention & control. Nitric Oxide / administration & dosage. Renal Circulation / drug effects

  • MedlinePlus Health Information. consumer health - Kidney Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Can J Physiol Pharmacol. 2008 Jan-Feb;86(1-2):55-63 [18418447.001]
  • [Cites] Proc Am Thorac Soc. 2006 Apr;3(2):153-60 [16565424.001]
  • [Cites] J Renal Inj Prev. 2015 Sep 01;4(3):61-7 [26468476.001]
  • [Cites] Kidney Int. 2007 Feb;71(4):290-7 [17200681.001]
  • [Cites] N Engl J Med. 2006 Jun 8;354(23):2473-83 [16760447.001]
  • [Cites] Eur J Intern Med. 2015 May;26(4):285-91 [25862494.001]
  • [Cites] J Clin Invest. 1998 Jun 1;101(11):2497-505 [9616221.001]
  • [Cites] Anaesthesia. 2000 May;55(5):442-9 [10792135.001]
  • [Cites] Kidney Res Clin Pract. 2015 Dec;34(4):194-200 [26779421.001]
  • [Cites] Nitric Oxide. 2006 May;14(3):261-71 [16545587.001]
  • [Cites] Br J Anaesth. 1997 Nov;79(5):631-40 [9422904.001]
  • [Cites] Crit Care. 2015 Apr 03;19:137 [25887847.001]
  • [Cites] J Clin Invest. 2007 Sep;117(9):2583-91 [17717604.001]
  • [Cites] Am J Med. 1999 Dec 13;107(6A):65S-70S; discussion 70S-71S [10628595.001]
  • [Cites] J Clin Invest. 2001 Jul;108(2):279-87 [11457881.001]
  • [Cites] Kidney Int. 2014 Aug;86(2):414-22 [24429400.001]
  • [Cites] Br J Anaesth. 2015 Dec;115 Suppl 2:ii3-14 [26658199.001]
  • [Cites] Am J Kidney Dis. 1996 Jul;28(1 Suppl 1):S56-62 [8669431.001]
  • [Cites] Clin Kidney J. 2016 Apr;9(2):192-200 [26985368.001]
  • [Cites] Stat Med. 2000 Jul 15;19(13):1793-819 [10861779.001]
  • [Cites] Br J Pharmacol. 1996 Sep;119(2):388-92 [8886425.001]
  • [Cites] Inflamm Res. 1998 Oct;47 Suppl 2:S78-87 [9831328.001]
  • [Cites] Adv Chronic Kidney Dis. 2013 Jan;20(1):67-75 [23265598.001]
  • [Cites] Am J Physiol. 1991 Oct;261(4 Pt 2):F726-33 [1928382.001]
  • [Cites] Am J Physiol Renal Physiol. 2002 Jul;283(1):F68-72 [12060588.001]
  • [Cites] Perioper Med (Lond). 2012 Jul 04;1:6 [24764522.001]
  • [Cites] J Thorac Cardiovasc Surg. 2004 Jan;127(1):44-50 [14752411.001]
  • [Cites] Curr Opin Nephrol Hypertens. 1995 Nov;4(6):505-9; discussion 503-4 [8591059.001]
  • [Cites] J Chromatogr B Biomed Sci Appl. 1997 Dec 5;703(1-2):25-36 [9448059.001]
  • [Cites] Vet Pathol. 2012 Mar;49(2):344-56 [21441112.001]
  • [Cites] Br J Anaesth. 2001 Feb;86(2):267-9 [11573671.001]
  • [Cites] Am J Med. 1999 May 31;106(5B):13S-24S [10390124.001]
  • [Cites] Clin Med (Lond). 2013 Jun;13(3):233-8 [23760694.001]
  • [Cites] Nephron. 1992;62(1):104-7 [1436273.001]
  • [Cites] Acta Physiol (Oxf). 2006 Aug;187(4):433-46 [16866775.001]
  • [Cites] J Am Soc Nephrol. 2014 May;25(5):884-92 [24511126.001]
  • [Cites] J Am Soc Nephrol. 1991 Jun;1(12):1271-7 [1912389.001]
  • [Cites] J Clin Invest. 1945 May;24(3):388-404 [16695228.001]
  • [Cites] Pflugers Arch. 1985 Sep;405(1):66-9 [3932957.001]
  • [Cites] Circulation. 1991 Jun;83(6):2038-47 [2040056.001]
  • [Cites] Pharmaceuticals (Basel). 2010 Jul 21;3(7):2291-2321 [27713354.001]
  • [Cites] Kidney Int. 2013 Sep;84(3):457-67 [23636171.001]
  • [Cites] Anesthesiology. 2007 Feb;106(2):275-82 [17264721.001]
  • [Cites] Can J Anaesth. 2003 Oct;50(8):839-46 [14525827.001]
  • [Cites] Kidney Int. 2001 Apr;59(4):1439-47 [11260406.001]
  • [Cites] Clin Drug Investig. 2009;29(11):703-11 [19813773.001]
  • [Cites] PLoS One. 2014 May 14;9(5):e96594 [24827456.001]
  • (PMID = 28658254.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents, Non-Steroidal; 31C4KY9ESH / Nitric Oxide; 90Y4QC304K / Ketoprofen
  •  go-up   go-down


3. Krishna MB, Joseph A, Thomas PL, Dsilva B, Pillai SM, Laloraya M: Impaired Arginine Metabolism Coupled to a Defective Redox Conduit Contributes to Low Plasma Nitric Oxide in Polycystic Ovary Syndrome. Cell Physiol Biochem; 2017 Oct 20;43(5):1880-1892

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Impaired Arginine Metabolism Coupled to a Defective Redox Conduit Contributes to Low Plasma Nitric Oxide in Polycystic Ovary Syndrome.
  • BACKGROUND: Though oxidative stress is associated with Polycystic Ovary Syndrome (PCOS), the status of nitric oxide is still unclear.
  • Nitric Oxide (NO) plays pivotal roles in many physiological functions which are compromised in PCOS.
  • We analysed NOx (nitrite+nitrate) and hydrogen peroxide (H2O2) concentrations, transcript levels of endothelial nitric oxide synthase (eNOS)/inducible nitric oxide synthase (iNOS) and arginine modulators, hydrogen peroxide regulators in the cohort.
  • RESULTS: PCOS women showed reduced plasma NOx(nitrate+nitrite) and H2O2 compared to controls.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 The Author(s). Published by S. Karger AG, Basel.
  • (PMID = 29055959.001).
  • [ISSN] 1421-9778
  • [Journal-full-title] Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
  • [ISO-abbreviation] Cell. Physiol. Biochem.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; Arginine bioavailability / Hydrogen peroxide / Nitric Oxide Synthase / Nitric oxide / Polycystic ovarian syndrome
  •  go-up   go-down


Advertisement
4. Sacco SA, Adolfsen KJ, Brynildsen MP: An integrated network analysis identifies how ArcAB enables metabolic oscillations in the nitric oxide detoxification network of Escherichia coli. Biotechnol J; 2017 Aug;12(8)

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An integrated network analysis identifies how ArcAB enables metabolic oscillations in the nitric oxide detoxification network of Escherichia coli.
  • The virulences of many pathogens depend on their abilities to detoxify the immune antimicrobial nitric oxide (NO•).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
  • (PMID = 28449226.001).
  • [ISSN] 1860-7314
  • [Journal-full-title] Biotechnology journal
  • [ISO-abbreviation] Biotechnol J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Keywords] NOTNLM ; Hmp / Microaerobic / Nitric oxide dioxygenase / Two component system / cydAB
  •  go-up   go-down


5. Takeno S, Yoshimura H, Kubota K, Taruya T, Ishino T, Hirakawa K: Comparison of Nasal Nitric Oxide Levels between the Inferior Turbinate Surface the Middle Meatus in Patients with Symptomatic Allergic Rhinitis. Allergol Int; 2014;63(3):475-483
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparison of Nasal Nitric Oxide Levels between the Inferior Turbinate Surface the Middle Meatus in Patients with Symptomatic Allergic Rhinitis.
  • BACKGROUND: Because of the anatomical complexity and the high output of the human nose, it has been unclear whether nasal nitric oxide (NO) serves as a reliable marker of allergic rhinitis (AR).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2014 Japanese Society of Allergology.
  • (PMID = 28942935.001).
  • [ISSN] 1440-1592
  • [Journal-full-title] Allergology international : official journal of the Japanese Society of Allergology
  • [ISO-abbreviation] Allergol Int
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; allergic rhinitis / exhaled nitric oxide / inferior turbinate / nasal nitric oxide / nitrotyrosine
  •  go-up   go-down


6. Yeo J, Woo HS, Lee SM, Kim YJ, Kwon KA, Park DK, Kim JH, Kim KO, Chung JW: Drug-induced eosinophilic pneumonia in a patient with Crohn's disease: diagnosis and treatment using fraction of exhaled nitric oxide. Intest Res; 2017 Oct;15(4):529-534

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Drug-induced eosinophilic pneumonia in a patient with Crohn's disease: diagnosis and treatment using fraction of exhaled nitric oxide.
  • Reports of pulmonary toxicity induced by oral 5-aminosalicylic acid agents or azathioprine in patients with inflammatory bowel disease are very rare; to date, only 38 cases have been reported worldwide.
  • We also found that the fraction of exhaled nitric oxide level was elevated in this patient.
  • After treatment, the fraction of exhaled nitric oxide level decreased and the symptoms improved.
  • The present case shows that fraction of exhaled nitric oxide is related to the disease activity and treatment effectiveness of druginduced eosinophilic pneumonia.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29142522.001).
  • [ISSN] 1598-9100
  • [Journal-full-title] Intestinal research
  • [ISO-abbreviation] Intest Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Keywords] NOTNLM ; Azathioprine / Crohn disease / Mesalamine / Nitric oxide / Pulmonary eosinophilia
  •  go-up   go-down


7. Zhang HQ, Zhang HQ, Zhang JJ, Liu YD, Deng YL, Luo JF, Niu HH, Sun X: [Application of pulmonary function and fractional exhaled nitric oxide tests in the standardized management of bronchial asthma in children]. Zhongguo Dang Dai Er Ke Za Zhi; 2017 Apr;19(4):419-424
Hazardous Substances Data Bank. NITRIC OXIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Application of pulmonary function and fractional exhaled nitric oxide tests in the standardized management of bronchial asthma in children].
  • OBJECTIVE: To investigate the changes of pulmonary function and fractional exhaled nitric oxide (FeNO) in the standardized treatment of bronchial asthma in children.
  • The pulmonary function parameters included forced expiratory volume in one second (FEV1), peak expiratory flow (PEF), maximal mid-expiratory flow (MMEF), and mid-expiratory flow at 25%, 50%, and 75% of vital capacity (MEF25, MEF50, and MEF75).
  • Another 62 healthy children were selected as the control group, and the pulmonary function and FeNO levels were measured only once.
  • Before treatment, there was a significant negative correlation between FeNO levels and pulmonary function parameters (P<0.05).
  • CONCLUSIONS: With the standardized treatment of bronchial asthma in children, pulmonary function parameters gradually increase and FeNO levels gradually decrease.
  • [MeSH-major] Asthma / therapy. Breath Tests. Lung / physiopathology. Nitric Oxide / analysis

  • Genetic Alliance. consumer health - Asthma.
  • MedlinePlus Health Information. consumer health - Asthma.
  • MedlinePlus Health Information. consumer health - Asthma in Children.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28407829.001).
  • [ISSN] 1008-8830
  • [Journal-full-title] Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
  • [ISO-abbreviation] Zhongguo Dang Dai Er Ke Za Zhi
  • [Language] chi
  • [Publication-type] Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 31C4KY9ESH / Nitric Oxide
  •  go-up   go-down


8. Shrestha SK, Shrestha S, Sharma L, Pant S, Neopane A: Comparison of fractional exhaled nitric oxide levels in chronic obstructive pulmonary disease, bronchial asthma and healthy subjects of Nepal. J Breath Res; 2017 Sep 13;11(4):047101

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparison of fractional exhaled nitric oxide levels in chronic obstructive pulmonary disease, bronchial asthma and healthy subjects of Nepal.
  • INTRODUCTION: Fractional exhaled nitric oxide levels in exhaled breath can indicate ongoing eosinophilic airway inflammation, specifically in asthma.
  • But its utility is being explored for central airway inflammations, including chronic obstructive pulmonary disease.
  • Normal levels of fractional exhaled nitric oxide (F<sub>E</sub>NO<sub>50</sub>) have been defined in different studies but not in Nepal.
  • This study compares F<sub>E</sub>NO<sub>50</sub> levels in normal subjects, asthma and chronic obstructive pulmonary disease.
  • METHODS: Single breath estimation of F<sub>E</sub>NO<sub>50</sub> was measured by a handheld electrochemical sensor-based device in normal non-smoking adults (n = 106), clinically controlled asthma (n = 106) and stable chronic obstructive pulmonary disease (n = 106).
  • RESULTS: The geometric mean for F<sub>E</sub>NO<sub>50</sub> was 14 parts per billion (ppb) with a median of 16 ppb, first quartile at 11 ppb and third quartile at 20 ppb in normal non-smoking adults.
  • CONCLUSIONS: F<sub>E</sub>NO<sub>50</sub> levels were higher in bronchial asthma (despite disease control) than in normal non-smoking adults and subjects with stable chronic obstructive pulmonary disease.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28686173.001).
  • [ISSN] 1752-7163
  • [Journal-full-title] Journal of breath research
  • [ISO-abbreviation] J Breath Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


9. Madhu BP, Singh KP, Saminathan M, Singh R, Shivasharanappa N, Sharma AK, Malik YS, Dhama K, Manjunatha V: Role of nitric oxide in the regulation of immune responses during rabies virus infection in mice. Virusdisease; 2016 Dec;27(4):387-399

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Role of nitric oxide in the regulation of immune responses during rabies virus infection in mice.
  • : Rabies virus (RABV) stimulates nitric oxide (NO) production, which either triggers T cell differentiation or suppresses T cell function depending on its concentration.
  • The experimental animals were divided into four groups and 100LD<sub>50</sub> of challenge virus standard (CVS) strain of RABV was inoculated intracerebrally on day 0 and subsequently aminoguanidine (AG; inducible nitric oxide synthase inhibitor) was injected intraperitoneally twice a day, up to 6 days.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28004019.001).
  • [ISSN] 2347-3584
  • [Journal-full-title] Virusdisease
  • [ISO-abbreviation] Virusdisease
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Keywords] NOTNLM ; Aminoguanidine / CD4+ / CD8+ T lymphocytes / Challenge virus standard strain / Natural killer cells / Rabies virus
  •  go-up   go-down


10. Al-Ali MK, Howarth PH: Exhaled nitric oxide levels in exacerbations of asthma, chronic obstructive pulmonary disease and pneumonia. Saudi Med J; 2001 Mar;22(3):249-53
Hazardous Substances Data Bank. NITRIC OXIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Exhaled nitric oxide levels in exacerbations of asthma, chronic obstructive pulmonary disease and pneumonia.
  • OBJECTIVE: Nitric oxide is known to be present in the exhaled air of normal subjects and at higher concentrations in asthmatics.
  • The aim of this study was to measure exhaled nitric oxide levels in patients admitted to hospital with acute exacerbations of asthma, or chronic obstructive pulmonary disease, or with pneumonia.
  • METHODS: Within 24 hours of admission exhaled nitric oxide levels were measured by a chemiluminescent analyzer in 11 patients with acute sever asthma, 19 patients with acute exacerbation of chronic obstructive pulmonary disease, and in 12 patients with pneumonia.
  • RESULTS: On admission median exhaled nitric oxide levels (range) were significantly higher in asthmatics 22 (9.3-74) parts per billion in comparison to patients with chronic obstructive pulmonary disease 10.3 (2.7-34) parts per billion; p < 0.01, pneumonia 7 (4-17) parts per billion; p<0.001, and normal subjects 8.7 (5-13.3) parts per billion; p < 0.001.
  • Following treatment the asthmatics had a significant reduction in their exhaled nitric oxide levels from 22 (9.3-74) parts per billion on day 1 to 9.7 (5.7-18.3) parts per billion on day 28; p = 0.005.
  • A strong negative correlation existed between peak expiratory flow rate measurements and exhaled nitric oxide levels in asthmatics on day 28 (r = -0.70; p = 0.017).
  • CONCLUSION: Acute exacerbations of asthma are associated with increased levels of exhaled nitric oxide in contrast to exacerbations of chronic obstructive pulmonary disease and acute pneumonia.
  • Exhaled nitric oxide may be a useful indirect marker of asthmatic airway inflammation.
  • The differing time course of response of nitric oxide to peak flow measures suggests that these two measures are reflecting differing airway events.
  • [MeSH-major] Asthma / metabolism. Breath Tests. Lung Diseases, Obstructive / metabolism. Nitric Oxide / analysis. Pneumonia / metabolism






Advertisement